ACHE and Alzheimer disease: A variety of cholinergic drugs has been approved in clinical trials to treat or enhance AD, exerting therapeutic effects by preventing ACh insufficiency and thereby increasing ACh levels in the brain, hydrolyzed by acetylcholinesterase (AChE) [3].